FDA Inspection
ImpactLifeImpactLife – FDA Inspection, May 18, 2022
Record Details
This FDA Inspection record concerns ImpactLife, with an inspection on May 18, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- ImpactLife
- Inspection Date
- May 18, 2022
- Product Type
- Biologics
View Company Profile
ID · d5bb604a-d2b3-469b-b662-29bee4f85201
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1172085
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of ImpactLife
7| Date | Classification | Office | Project area |
|---|---|---|---|
| January 24, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 23, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 17, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 22, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 7, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for ImpactLife
- FDA Inspection 1259431 - 2025-01-24
- FDA Inspection 1051874 - 2018-04-23
- FDA Inspection 961380 - 2016-02-17
- FDA Inspection 875787 - 2014-04-22
- FDA Inspection 781241 - 2012-05-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.